Advertisement

Journal of Neurology

, Volume 252, Issue 10, pp 1245–1248 | Cite as

Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland

  • C. McGuigan
  • C. Dunne
  • J. Crowley
  • R. Hagan
  • G. Rooney
  • E. Lawlor
  • M. Hutchinson
ORIGINAL COMMUNICATION

Abstract

Background

A recent epidemiological study of multiple sclerosis in County Donegal in the northwest of Ireland and County Wexford in the southeast found a significant prevalence difference of 63.9/100,000 (95% CI 49.3–82.7/100,000) between the two regions (Z = 3.94, p ≤ 0.001). County Donegal had a higher prevalence rate than County Wexford (184.6/100,000 vs. 120.7/ 100,000). The aim of this paper is to examine whether the MS prevalence difference between the two counties is due to population differences in the genetic predisposition to MS.

Methods

Seventy–three MS patients from County Donegal and 45 from County Wexford participated in the study and 200 control subjects were enrolled from each county. Blood samples from both MS populations and control populations were HLA typed for DRB1 and DQB1 alleles.

Results

The strong association with the development of MS and the HLA DRB1*1501 and DQB1*0602 phenotypes was confirmed in both patient populations relative to controls. The Donegal sample control population also had a significantly higher carriage rate of the HLA DRB1*1501 – DQB1*0602 haplotype relative to the Wexford sample control population (χ2 = 5.02, p ≤ 0.05,OR = 1.616, CI 1.060–2.464, p = 0.05).

Conclusion

Although the numbers tested in this study were small the results suggest one of the factors accounting for the difference in MS prevalence across the island of Ireland is likely to be variation in the genetic predisposition to MS within the Irish population.

Key words

genetics of multiple sclerosis MS (genetic) epidemiology epidemiology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Al-Din ASN, al-Saffar M, Siboo, Behbehani K (1986) Association between HLA-D region epitopes and multiple sclerosis in Arabs. Tissue Antigens 27:196–200PubMedGoogle Scholar
  2. 2.
    Cullen CG, Middleton D, Savage DA, Hawkins S (1991) HLA DR and -DQ Genotyping in Multiple Sclerosis patients in Northern Ireland. Hum Immunol 30:1–6PubMedGoogle Scholar
  3. 3.
    Downie AW, Phadke JG (1984) The Chief Scientists reports: multiple sclerosis in north east Scotland. Health Bulletin (Edin) 42:151–156PubMedGoogle Scholar
  4. 4.
    Ebers GC, Sadovnick AD (1994) The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 54:1–17CrossRefPubMedGoogle Scholar
  5. 5.
    Ebers GC, Sadovnick AD, Risch NJ (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative study group. Nature 377:150–151CrossRefPubMedGoogle Scholar
  6. 6.
    Epplen C, Jackel S, Santos EJ, et al. (1997) Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol 41:341–352CrossRefPubMedGoogle Scholar
  7. 7.
    GAMES and the Transatlantic Multiple Sclerosis Genetics Cooperative (2003) A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol 143:39–46CrossRefPubMedGoogle Scholar
  8. 8.
    Jerslid C, Fog T, Hansen GS, et al. (1973) Histocompatibility determinants in multiple sclerosis,with special reference to clinical course. Lancet 2:1221–1225CrossRefPubMedGoogle Scholar
  9. 9.
    Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMedGoogle Scholar
  10. 10.
    Marrosu MG, Murru MR, Costa G, et al. (1997) Multiple sclerosis in Sardinia is associated and linked with HLA-DR3 and -DR4. Am J Hum Gen 61:454–457Google Scholar
  11. 11.
    McDonnell GV, Mawhinney H, Graham CA, et al. (1999) A study of the HLADR region in clinical subtypes of multiple sclerosis and its influence on prognosis. J Neurol Sci 165:77–83CrossRefPubMedGoogle Scholar
  12. 12.
    McGuigan C, McCarthy A, Quigley C, et al. (2004) Latitudinal variation in the prevalence of multiple sclerosis in Ireland: an effect of genetic diversity. J Neurol Neurosurg Psychiatry 75:572–576CrossRefPubMedGoogle Scholar
  13. 13.
    Mumford CJ, Wood NW, Kellar-Wood HF, et al. (1994) The British Isles survey of multiple sclerosis in twins. Neurology 44:11–15PubMedGoogle Scholar
  14. 14.
    Poser C (1994) The dissemination of multiple sclerosis: a Viking saga? A historical essay. Ann Neurol 36:S231–S243CrossRefPubMedGoogle Scholar
  15. 15.
    Poser CM, Paty DW, Scheinberg L, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231CrossRefPubMedGoogle Scholar
  16. 16.
    Sadovnick AD, Armstrong H, Rice G, et al. (1993) A population based study of multiple sclerosis in twins: update. Ann Neurol 33:281–285CrossRefPubMedGoogle Scholar
  17. 17.
    Swingler RJ, Kirk PF, Darke C, Compston DAS (1987) HLA and multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry 50:1153–1155PubMedGoogle Scholar
  18. 18.
    Willers C, Ebers G (2000) Susceptibility to multiple sclerosis: interplay between genes and environment. Curr Opin Neurol 13:241–247PubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2005

Authors and Affiliations

  • C. McGuigan
    • 1
    • 2
  • C. Dunne
    • 3
  • J. Crowley
    • 3
  • R. Hagan
    • 3
  • G. Rooney
    • 3
  • E. Lawlor
    • 3
  • M. Hutchinson
    • 1
  1. 1.Dept. of NeurologySt. Vincent’s University HospitalDublinIreland
  2. 2.Dept. of NeurologySt. Mary’s HospitalLondon, W2 INYUK
  3. 3.National Tissue Typing ReferenceLaboratory Irish Blood Transfusion Service National Blood CentreDublinIreland

Personalised recommendations